LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 68

Search options

  1. Article ; Online: Antibiotikaallergien – gezieltes Vorgehen bei vermeintlicher β‑Laktam-Allergie.

    Hornuß, Daniel / Rieg, Siegbert

    Innere Medizin (Heidelberg, Germany)

    2023  Volume 64, Issue 4, Page(s) 351–361

    Abstract: Allergic reactions to antibiotics belong to hypersensitivity drug reactions and can trigger both immunoglobulin E-mediated symptoms and T cell-mediated symptoms. Skin manifestations are the most common symptoms. Although reporting a penicillin allergy ... ...

    Title translation Antibiotic allergies: targeted approach in suspected β‑lactam allergy.
    Abstract Allergic reactions to antibiotics belong to hypersensitivity drug reactions and can trigger both immunoglobulin E-mediated symptoms and T cell-mediated symptoms. Skin manifestations are the most common symptoms. Although reporting a penicillin allergy results in considerable restrictions in the treatment of acute infections, which may be associated with poor treatment outcomes, in most cases the label 'penicillin allergy' is not called into question or critically reviewed. However, in 85-90% of patients, 'penicillin allergy' constitutes a mislabeling of a non-specific intolerance reaction that does not pose a risk to the patient when re-exposed to penicillins. Careful history taking, an evaluation of manifestations in the past, and easy-to-perform initial diagnostic steps are crucial in differentiating non-specific intolerance reactions from penicillin allergy sensu stricto. Thus, a penicillin de-labeling strategy allows for optimized antibiotic therapy in the event of a future infection. Although allergic cross-reactivity between different β‑lactam antibiotics can occur, the risk for a severe cross-reactivity is dependent on chemical properties of the specific β‑lactam. Published cross-reactivity tables can help in risk stratification and choice of alternative β‑lactam agents.
    MeSH term(s) Humans ; beta-Lactams/adverse effects ; Anti-Bacterial Agents/adverse effects ; Drug Hypersensitivity/diagnosis ; Penicillins/adverse effects ; Hypersensitivity
    Chemical Substances beta-Lactams ; Anti-Bacterial Agents ; Penicillins
    Language German
    Publishing date 2023-03-14
    Publishing country Germany
    Document type English Abstract ; Journal Article
    ISSN 2731-7099
    ISSN (online) 2731-7099
    DOI 10.1007/s00108-023-01490-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Antibiotikaallergien – gezieltes Vorgehen bei vermeintlicher β‑Laktam-Allergie.

    Hornuß, Daniel / Rieg, Siegbert

    Urologie (Heidelberg, Germany)

    2023  Volume 62, Issue 10, Page(s) 1096–1106

    Abstract: Allergic reactions to antibiotics belong to hypersensitivity drug reactions and can trigger both immunoglobulin E-mediated symptoms and T cell-mediated symptoms. Skin manifestations are the most common symptoms. Although reporting a penicillin allergy ... ...

    Title translation Antibiotic allergies: targeted approach in suspected β‑lactam allergy.
    Abstract Allergic reactions to antibiotics belong to hypersensitivity drug reactions and can trigger both immunoglobulin E-mediated symptoms and T cell-mediated symptoms. Skin manifestations are the most common symptoms. Although reporting a penicillin allergy results in considerable restrictions in the treatment of acute infections, which may be associated with poor treatment outcomes, in most cases the label 'penicillin allergy' is not called into question or critically reviewed. However, in 85-90% of patients, 'penicillin allergy' constitutes a mislabeling of a non-specific intolerance reaction that does not pose a risk to the patient when re-exposed to penicillins. Careful history taking, an evaluation of manifestations in the past, and easy-to-perform initial diagnostic steps are crucial in differentiating non-specific intolerance reactions from penicillin allergy sensu stricto. Thus, a penicillin de-labeling strategy allows for optimized antibiotic therapy in the event of a future infection. Although allergic cross-reactivity between different β‑lactam antibiotics can occur, the risk for a severe cross-reactivity is dependent on chemical properties of the specific β‑lactam. Published cross-reactivity tables can help in risk stratification and choice of alternative β‑lactam agents.
    MeSH term(s) Humans ; beta-Lactams/adverse effects ; Anti-Bacterial Agents/adverse effects ; Drug Hypersensitivity/diagnosis ; Penicillins/adverse effects ; Hypersensitivity
    Chemical Substances beta-Lactams ; Anti-Bacterial Agents ; Penicillins
    Language German
    Publishing date 2023-10-11
    Publishing country Germany
    Document type English Abstract ; Journal Article
    ISSN 2731-7072
    ISSN (online) 2731-7072
    DOI 10.1007/s00120-023-02191-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Chlamydien-Infektionen

    Hornuß, Daniel / Müller, Matthias C. / Rieg, Siegbert

    TumorDiagnostik & Therapie

    2023  Volume 44, Issue 08, Page(s) 572–574

    Language German
    Publishing date 2023-09-26
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2072365-9
    ISSN 1439-1279 ; 0722-219X
    ISSN (online) 1439-1279
    ISSN 0722-219X
    DOI 10.1055/a-2151-7110
    Database Thieme publisher's database

    More links

    Kategorien

  4. Article: Chlamydien-Infektionen

    Hornuß, Daniel / Müller, Matthias C. / Rieg, Siegbert

    Zeitschrift für Gastroenterologie

    2022  Volume 60, Issue 01, Page(s) 27–29

    Language German
    Publishing date 2022-01-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 201387-3
    ISSN 1439-7803 ; 0044-2771 ; 0172-8504
    ISSN (online) 1439-7803
    ISSN 0044-2771 ; 0172-8504
    DOI 10.1055/a-1438-5557
    Database Thieme publisher's database

    More links

    Kategorien

  5. Article ; Online: Lungensonografie bei Patienten mit Verdacht auf COVID-19 – Schritt-für-Schritt.

    Schmid, Bonaventura / Hornuß, Daniel / Feuerstein, Doreen / Schultheiß, Michael / Damjanovic, Domagoj

    Deutsche medizinische Wochenschrift (1946)

    2020  Volume 145, Issue 15, Page(s) 1100–1104

    Abstract: Pulmonary sonography can be a valuable aid in the differential diagnosis of a variety of cardiopulmonary diseases, including patients with COVID-19. Pulmonary sonography is an examination method that is also quickly available at the bedside without ... ...

    Title translation Pulmonary Sonography in Patients With Suspected COVID-19 - Step-by-Step.
    Abstract Pulmonary sonography can be a valuable aid in the differential diagnosis of a variety of cardiopulmonary diseases, including patients with COVID-19. Pulmonary sonography is an examination method that is also quickly available at the bedside without additional risks for the patient. When COVID-19 is suspected, lung sonography is a valuable component of initial diagnosis when used systematically, performed hygienically and correctly. However, the findings of pulmonary sonography must be placed in the clinical context; sonography does not replace the gold standard of PCR diagnosis. The article shows how this sonography is performed and which findings in COVID-19 are relevant.
    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/diagnostic imaging ; Diagnosis, Differential ; Humans ; Lung/diagnostic imaging ; Pandemics ; Pneumonia, Viral/diagnostic imaging ; SARS-CoV-2 ; Ultrasonography/methods
    Keywords covid19
    Language German
    Publishing date 2020-07-30
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 200446-x
    ISSN 1439-4413 ; 0012-0472
    ISSN (online) 1439-4413
    ISSN 0012-0472
    DOI 10.1055/a-1185-6885
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Already current practice? A snapshot survey on doxycycline use for prevention of sexually transmitted infections in parts of the German MSM community.

    Hornuss, Daniel / Mathé, Philipp / Usadel, Susanne / Zimmermann, Stefan / Müller, Matthias / Rieg, Siegbert

    Infection

    2023  Volume 51, Issue 6, Page(s) 1831–1834

    Abstract: Purpose: Recent studies point toward a potential benefit of doxycycline use for post-exposure prophylaxis (PEP) or pre-exposure prophylaxis (PrEP) to prevent sexually transmitted infections (STIs). Although prescribing doxycycline in a prophylactic ... ...

    Abstract Purpose: Recent studies point toward a potential benefit of doxycycline use for post-exposure prophylaxis (PEP) or pre-exposure prophylaxis (PrEP) to prevent sexually transmitted infections (STIs). Although prescribing doxycycline in a prophylactic intention is not generally recommended yet, we noticed an increasing number of inquiries from individuals within the LGBTQ community for doxycycline prescriptions.
    Methods: We conducted an anonymous online survey to evaluate the current extent of doxycycline use for PEP or PrEP within the LGBTQ community using REDCap electronic data capture tools. Participants gained access to the online survey through a QR code on posters in the premises of our STI outpatient department and at LGBTQ community-related events in the south-western region of Germany. Additional access was provided by a direct link shared on social media profiles for men having sex with men (MSM), transgender, and queers.
    Results: 96 of 99 responses were eligible for analysis. Twenty-two participants (23%) indicated to have already used doxycycline for PEP and six participants (6%) used doxycycline for PrEP. The majority of participants used pills left over from previous doxycycline treatment. Forty percent of indicated modes of access were without a regular prescription, e.g., by provision from acquaintances (with or without healthcare profession) or by ordering online.
    Conclusion: Our study shows that the concept of doxycycline use for prevention of STIs is already well known and applied in the LGBTQ community. Further analysis, especially modeling studies, are needed to evaluate strategies aiming to reduce doxycycline intake (PEP/PrEP versus repeated targeted therapies) and improve sexual health outcomes within the community.
    MeSH term(s) Male ; Humans ; HIV Infections ; Doxycycline/therapeutic use ; Homosexuality, Male ; Sexual and Gender Minorities ; Sexually Transmitted Diseases/prevention & control ; Pre-Exposure Prophylaxis
    Chemical Substances Doxycycline (N12000U13O)
    Language English
    Publishing date 2023-08-22
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-023-02086-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen

    Hornuß, Daniel / Laubner, Katharina / Monasterio, Carmen / Thimme, Robert / Wagner, D.

    Pneumologie. - 74,

    2020  Volume 09, Issue , 615-620, ISSN: 1438-8790

    Keywords covid19
    Language German
    Publishing country de
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Osteoartikuläre und rheumatologische Manifestationen sexuell übertragbarer Infektionen

    Hornuss, Daniel / Giesen, Roland / Rieg, Siegbert

    Arthritis und Rheuma

    2022  Volume 42, Issue 02, Page(s) 93–99

    Abstract: Sexuell übertragbare Infektionen (STI) können Symptome einer rheumatologischen Erkrankung imitieren oder das Auftreten einer solchen begünstigen. Insbesondere chronisch verlaufende Erkrankungen wie HIV oder Syphilis stellen den Kliniker aufgrund der ... ...

    Abstract Sexuell übertragbare Infektionen (STI) können Symptome einer rheumatologischen Erkrankung imitieren oder das Auftreten einer solchen begünstigen. Insbesondere chronisch verlaufende Erkrankungen wie HIV oder Syphilis stellen den Kliniker aufgrund der mannigfaltigen Symptomkomplexe vor große Herausforderungen. Andere sexuell übertragbare Erreger wie Chlamydien oder Gonokokken können ebenfalls autoimmunologische Inflammationsreaktionen oder akute septische Arthritiden hervorrufen. Vor Einleitung einer immunmodulierenden Therapie sollte daher eine Abklärung hinsichtlich sexuell übertragbarer Infektionen in Betracht gezogen werden. Dies gilt insbesondere bei jüngeren, sexuell aktiven Patient*innen oder Patientengruppen mit Risikoverhalten (z. B. MSM, Sex-Arbeiter*innen). Bei Nachweis einer STI sollte stets ein Screening auf mögliche Co-Infektionen mit weiteren STI erfolgen.

    Sexually transmitted infections (STI) can mimic symptoms or promote the development of rheumatological diseases. Especially the variety of symptoms in the context of HIV infection or syphilis pose a challenge to clinicians. Other sexually transmitted pathogens like chlamydia or gonococci can also induce autoimmunological inflammatory disorders or cause acute septic arthritis. Before initiation of treatment with immunomodulatory agents, testing for possible sexually transmitted infections should be considered, especially in patients, who are sexually active or at risk for STIs (MSM, commercial sex workers). If a STI is diagnosed, screening for possible co-infections with other STIs is recommended.
    Keywords HIV ; Syphilis ; STI ; Autoimmunerkrankungen ; HIV ; Syphilis ; STI ; autoimmune diseases
    Language German
    Publishing date 2022-04-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2223481-0
    ISSN 2567-5753 ; 0176-5167
    ISSN (online) 2567-5753
    ISSN 0176-5167
    DOI 10.1055/a-1755-4618
    Database Thieme publisher's database

    More links

    Kategorien

  9. Article: Osteoartikuläre und rheumatologische Manifestationen sexuell übertragbarer Infektionen

    Hornuss, Daniel / Giesen, Roland / Rieg, Siegbert

    Arthritis + Rheuma

    2022  Volume 42, Issue 2, Page(s) 93

    Language German
    Document type Article
    ZDB-ID 605764-0
    ISSN 0176-5167
    Database Current Contents Medicine

    More links

    Kategorien

  10. Article ; Online: Klinischer Nutzen von Tocilizumab und anderen immunmodulatorischen Substanzen bei COVID-19.

    Hornuss, Daniel / Giesen, Roland / Biever, Paul / Kern, Winfried V

    Deutsche medizinische Wochenschrift (1946)

    2021  Volume 146, Issue 23, Page(s) 1538–1542

    Abstract: The pathophysiological course of COVID-19 can be distinguished in a phase of viral replication and an inflammatory phase. Hyperinflammatory processes promote the development of severe COVID-19. Therefore, immunomodulating agents came into focus. ... ...

    Title translation Clinical benefit of Tocilizumab and other immunomodulating agents for treatment of COVID-19.
    Abstract The pathophysiological course of COVID-19 can be distinguished in a phase of viral replication and an inflammatory phase. Hyperinflammatory processes promote the development of severe COVID-19. Therefore, immunomodulating agents came into focus. Dexamethasone has already become standard of care for treatment of severe COVID-19. Two large randomized trials and a meta-analysis of collectively nine randomized trials showed a reduced mortality in patients with severe COVID-19 if Tocilizumab - an IL-6-rezeptor antagonist - was added to standard of care. Treatment with Baricitinib - a JAK 1/2 inhibitor - may also be beneficial for patients without or on low oxygen supplementation. National and international guidelines recommend Tocilizumab for treatment of severe COVID-19. Treatment with JAK inhibitors is an option for hospitalized patients with moderate COVID-19. It should be emphasized that comedication of JAK inhibitors and Tocilizumab is not recommended. Further high quality research is required for the widespread use of immunomodulating agents in COVID-19.
    MeSH term(s) Antibodies, Monoclonal, Humanized/therapeutic use ; Azetidines/therapeutic use ; COVID-19/drug therapy ; Humans ; Immunomodulating Agents/therapeutic use ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Sulfonamides/therapeutic use
    Chemical Substances Antibodies, Monoclonal, Humanized ; Azetidines ; Immunomodulating Agents ; Purines ; Pyrazoles ; Sulfonamides ; tocilizumab (I031V2H011) ; baricitinib (ISP4442I3Y)
    Language German
    Publishing date 2021-11-26
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 200446-x
    ISSN 1439-4413 ; 0012-0472
    ISSN (online) 1439-4413
    ISSN 0012-0472
    DOI 10.1055/a-1643-4209
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top